LONA

NASDAQ 已收盘

LeonaBio

2.02 USD
▼-0.44-17.89%
盘后 1.99 -1.49%
2026-11-20
市值
$19.03M
市盈率
—
EPS
-8.68
股息率
—
52 周区间
1.91 – 14.21
成交量
68.87K
Beta
1.92
目标价
16.00
52W 低 1.9152W 高 14.21
价格走势

公司简介

LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company’s lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clini...